Retention among transgender women treated with dolutegravir associated with tenofovir/lamivudine or emtricitabine in Argentina: TransViiV study.
In Argentina, transgender women (TGW) have a high HIV prevalence (34%). However, this population shows lower levels of adherence, retention in HIV care and viral suppression than cisgender patients. The World Health Organization (WHO) recommends the transition to dolutegravir (DTG)-based regimens to...
Gardado en:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Public Library of Science (PLoS)
2023-01-01
|
| Series: | PLoS ONE |
| Acceso en liña: | https://doi.org/10.1371/journal.pone.0279996 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|